Company: CRNX
Filing Date: 2025-04-23
Form Type: DEF 14A
Source: 0000950170-25-057452
Chunk: 75

Company: Crinetics Pharmaceuticals, Inc.
Filing Date: 2025-04-23
Form: DEF 14A
Chunk 75
---
s, following which they approve equity awards for NEOs as well as any other stock option award recipients, typically in late February or early March . On occasion, the compensation committee may grant equity awards outside of our annual grant cycle for new hires, promotions, recognition, retention, or other purposes. While the compensation committee has discretionary authority to grant equity awards outside of the cycle described above, it does not have a practice or policy of granting equity awards in anticipation of the release of material non-public information and we do not time the release of material non-public information in coordination with grants of equity awards in a manner that intentionally affects the value of executive compensation.

The following table contains information required by Item 402(x) of Regulation S-K about stock options granted to our NEOs in the last completed fiscal year during the period from four business days before to one business day after the filing of a Current Report Form 8-K that disclosed material nonpublic information. Pursuant to this SEC rule, we are providing the following information relating to stock options awarded to our NEOs on March 4, 2024, one business day after the date the Company filed its Current Report Form 8-K on March 1, 2024. The $43.51 exercise price of the stock options was based on the closing price of a share of our common stock on March 4, 2024. The Company did not grant any stock options to NEOs of the Company in the last completed fiscal year during the period from four business days before to one business day after the filing of any of the Company’s Quarterly Reports on Form 10-Q, or the filing of the Company’s Annual Report on Form 10-K.

| Name                      |     | Grant Date |     | Number of Securities Underlying the Award |         |     | Exercise Price of the Award ($/sh) |       |     | Grant Date Fair Value of the Award ($) |           |     | Percentage change in the             
 closing market price of              
 the securities underlying the award  
 between the trading day ending       
 immediately prior to the disclosure  
 of material nonpublic information    
 and the trading day beginning        
 immediately following the disclosure 
 of material nonpublic information    |      |   |
| R. Scott Struthers, Ph.D. |     | 3/4/2024   |     |                                           | 240,000 |     |                                    | 43.51 |     |                                        | 6,640,800 |     |                                      | 6.28 | % |